Skip to main content

Published locations for FDA grants zanubrutinib an accelerated approval in marginal zone lymphoma

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA grants zanubrutinib an accelerated approval in marginal zone lymphoma

User login

  • Reset your password
  • /content/fda-grants-zanubrutinib-accelerated-approval-marginal-zone-lymphoma
  • /hematologynews/article/246191/b-cell-lymphoma/fda-grants-zanubrutinib-accelerated-approval-marginal
  • /oncologypractice/article/246191/b-cell-lymphoma/fda-grants-zanubrutinib-accelerated-approval
  • /jcomjournal/article/246191/b-cell-lymphoma/fda-grants-zanubrutinib-accelerated-approval-marginal
  • /hematology-oncology/article/246191/b-cell-lymphoma/fda-grants-zanubrutinib-accelerated-approval
  • /b-cell-lymphoma-icymi/article/246191/b-cell-lymphoma/fda-grants-zanubrutinib-accelerated-approval